secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virpax Pharmaceuticals, Inc. (—)
CIK:        0001708331
Form:       8-K
Filed at:   2024-11-29T23:59:59+00:00
Accession:  0001731122-24-001899
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virpax Pharmaceuticals reduces shareholder meeting quorum threshold to 34%
--------------------------------------------------------------------------

- Amendment adopted November 27, 2024, lowering quorum from a majority to 34% of voting power.
- Change applies to all future shareholder meetings; filed as Exhibit 3.1.
- Bylaw modification may ease passage of shareholder proposals and director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708331/000173112224001899/0001731122-24-001899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708331/000173112224001899/e6175_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer